NCT02031991 - A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01) | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Healthy

Interventions

BIOLOGICAL

PF-06439535

Solution for intravenous infusion, single dose of 5mg/kg, administered as 90-minute infusion.

BIOLOGICAL

Avastin

Solution for intravenous infusion, single dose of 5mg/kg, administered as 90-minute infusion.

BIOLOGICAL

Avastin

Solution for intravenous infusion, single dose of 5mg/kg, administered as 90-minute infusion.

Trial Locations (1)

Pfizer Investigational Site, South Miami